{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:32:11Z","timestamp":1794000731008,"version":"4.8.0"},"reference-count":244,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Depression and anxiety disorders are two of the most common and growing mental health concerns in adolescents. Consequently, antidepressant medication (AD) use has increased widely during the last decades. Several classes of antidepressants are used mainly to treat depression, anxiety, and obsessive-compulsive disorders by targeting relevant brain neurochemical pathways. Almost all randomized clinical trials of antidepressants examined patients with no concomitant medications or drugs. This does not address the expected course of therapy and outcome in cannabis users. Cannabis is the most commonly used illicit substance globally. Substantial changes in its regulation are recently taking place. Many countries and US states are becoming more permissive towards its medical and recreational use. The psychological and physiological effects of cannabis (mainly of its major components, tetrahydrocannabinol (THC) and cannabidiol (CBD)) have been extensively characterized. Cannabis use can be a risk factor for depressive and anxiety symptoms, but some constituents or mixtures may have antidepressant and\/or anxiolytic potential. The aim of this literature review is to explore whether simultaneous use of AD and cannabis in adolescence can affect AD treatment outcomes. Based on the current literature, it is reasonable to assume that antidepressants are less effective for adolescents with depression\/anxiety who frequently use cannabis. The mechanisms of action of antidepressants and cannabis point to several similarities and conjunctions that merit future investigation regarding the potential effectiveness of antidepressants among adolescents who consume cannabis regularly.<\/jats:p>","DOI":"10.3390\/ijerph19010523","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T03:41:32Z","timestamp":1641440492000},"page":"523","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Examining the Use of Antidepressants for Adolescents with Depression\/Anxiety Who Regularly Use Cannabis: A Narrative Review"],"prefix":"10.3390","volume":"19","author":[{"given":"Danielle","family":"Hen-Shoval","sequence":"first","affiliation":[{"name":"Psychology Department, Bar-Ilan University, Ramat Gan 5290002, Israel"},{"name":"Gonda Brain Research Center, Bar-Ilan University, Ramat Gan 5290002, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0663-4384","authenticated-orcid":false,"given":"Aron","family":"Weller","sequence":"additional","affiliation":[{"name":"Psychology Department, Bar-Ilan University, Ramat Gan 5290002, Israel"},{"name":"Gonda Brain Research Center, Bar-Ilan University, Ramat Gan 5290002, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9765-8938","authenticated-orcid":false,"given":"Abraham","family":"Weizman","sequence":"additional","affiliation":[{"name":"Geha Mental Health Center, Petah Tiqva 4910002, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gal","family":"Shoval","sequence":"additional","affiliation":[{"name":"Geha Mental Health Center, Petah Tiqva 4910002, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"},{"name":"Princeton Neuroscience Institute, Princeton University, Princeton, NJ 08540, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.mcna.2017.03.010","article-title":"Screening Adults for Depression in Primary Care","volume":"101","author":"Smithson","year":"2017","journal-title":"Med. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3389\/fpsyg.2019.00543","article-title":"Child and adolescent depression: A review of theories, evaluation instruments, prevention programs, and treatments","volume":"10","author":"Bernaras","year":"2019","journal-title":"Front. Psychol."},{"key":"ref_3","unstructured":"World Health Organization (2017). Global Diffusion of eHealth: Making Universal Health Coverage Achievable: Report of the Third Global Survey on eHealth, World Health Organization."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S2352-4642(20)30109-7","article-title":"Mental health effects of school closures during COVID-19","volume":"4","author":"Lee","year":"2020","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1176\/appi.ajp.157.6.940","article-title":"Lost human capital from early-onset chronic depression","volume":"157","author":"Berndt","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1001\/jama.289.23.3078","article-title":"Researchers probe depression in children","volume":"289","author":"Voelker","year":"2003","journal-title":"JAMA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.281.18.1707","article-title":"Depressed adolescents grown up","volume":"281","author":"Weissman","year":"1994","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archpsyc.56.9.794","article-title":"Children with prepubertal-onset major depressive disorder and anxiety grown up","volume":"56","author":"Weissman","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00429-010-0258-9","article-title":"Interoception in anxiety and depression","volume":"214","author":"Paulus","year":"2010","journal-title":"Brain Struct. Funct."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/1469-7610.00424","article-title":"Comorbidity","volume":"40","author":"Angold","year":"1999","journal-title":"J. Child Psychol. Psychiatry Allied Discip."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archpsyc.59.10.893","article-title":"Psychiatric disorder, impairment, and service use in rural African American and white youth","volume":"59","author":"Angold","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"xi","DOI":"10.1016\/j.psc.2008.03.002","article-title":"Recent research in personality disorders. Preface","volume":"31","author":"Paris","year":"2008","journal-title":"Psychiatr. Clin. N. Am."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/00004583-199707000-00023","article-title":"Relationship of depressive, conduct, and comorbid disorders and social functioning in childhood","volume":"36","author":"Renouf","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"xiii","DOI":"10.1016\/j.psc.2008.03.001","article-title":"Suicidal behavior: A developmental perspective","volume":"31","author":"Oquendo","year":"2008","journal-title":"Psychiatr. Clin. N. Am."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/IJAMH.2007.19.1.91","article-title":"Triggers for suicidal behavior in depressed older adolescents and young adults: Do alcohol use disorders make a difference?","volume":"19","author":"Sher","year":"2007","journal-title":"Int. J. Adolesc. Med. Health"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1089\/cap.2006.16.767","article-title":"Substance use, suicidality, and adolescent-onset schizophrenia: An Israeli 10-year retrospective study","volume":"16","author":"Shoval","year":"2006","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/acer.12290","article-title":"Alcohol dependence and suicide-related ideation\/behaviors in an Israeli household sample, with and without major depression","volume":"38","author":"Shoval","year":"2014","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.comppsych.2006.05.002","article-title":"A 10-year retrospective study of inpatient adolescents with schizophrenia\/schizoaffective disorder and substance use","volume":"48","author":"Shoval","year":"2007","journal-title":"Compr. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1515\/IJAMH.2005.17.3.255","article-title":"Children\u2019s Depression Inventory (CDI) and the Children\u2019s Depression Rating Scale-Revised (CDRS-R): Reliability of the Hebrew version","volume":"17","author":"Zalsman","year":"2005","journal-title":"Int. J. Adolesc. Med. Health"},{"key":"ref_20","first-page":"9","article-title":"Depressive symptoms in adolescence: The role of gender and personality traits","volume":"2","author":"Sepede","year":"2015","journal-title":"Res. Adv. Psychiatry"},{"key":"ref_21","first-page":"1546","article-title":"Adolescent depression: Clinical features and therapeutic strategies","volume":"17","author":"Nardi","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_22","first-page":"513","article-title":"Affective and anxiety disorders: Prevalence, treatment and antidepressant medication use","volume":"44","author":"Hollingworth","year":"2010","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref_23","first-page":"420","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis","volume":"16","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.euroneuro.2016.02.001","article-title":"Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005\u20132012","volume":"26","author":"Bachmann","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/cap.2015.0187","article-title":"Evaluation of motivational interviewing to improve psychotropic medication adherence in adolescents","volume":"27","author":"Hamrin","year":"2017","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(16)30385-3","article-title":"Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: A network meta-analysis","volume":"388","author":"Cipriani","year":"2016","journal-title":"Lancet"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"101213","DOI":"10.1016\/j.smrv.2019.101213","article-title":"Efficacy of light therapy versus antidepressant drugs, and of the combination versus monotherapy, in major depressive episodes: A systematic review and meta-analysis","volume":"48","author":"Geoffroy","year":"2019","journal-title":"Sleep Med Rev."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Kirsch, I., Deacon, B.J., Huedo-Medina, T.B., Scoboria, A., Moore, T.J., and Johnson, B.T. (2008). Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Med., 5.","DOI":"10.1371\/journal.pmed.0050045"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","article-title":"Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple-treatments meta-analysis","volume":"373","author":"Cipriani","year":"2009","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-0447.2008.01179.x","article-title":"Antidepressant treatment is associated with a reduction in suicidal ideation and suicide attempts","volume":"118","author":"Mulder","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1192\/bjp.bp.109.065227","article-title":"Cannabis and suicide: Longitudinal study","volume":"195","author":"Price","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1570159X17666190903103923","article-title":"The \u201centourage effect\u201d: Terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders","volume":"18","author":"Ferber","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Hurst, T. (2019). World drug report. The Encyclopedia of Women and Crime, Wiley on line.","DOI":"10.1002\/9781118929803.ewac0543"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0140-6736(09)61037-0","article-title":"Adverse health effects of non-medical cannabis use","volume":"374","author":"Hall","year":"2010","journal-title":"Lancet"},{"key":"ref_35","first-page":"1922","article-title":"Adverse effects of cannabis on adolescent brain development: A longitudinal study","volume":"27","author":"Camchong","year":"2017","journal-title":"Cereb. Cortex"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/bcp.13703","article-title":"Clinical issues in cannabis use","volume":"84","author":"Bonomo","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.euroneuro.2020.04.009","article-title":"Experiences with medical cannabis in the treatment of veterans with PTSD: Results from a focus group discussion","volume":"36","author":"Krediet","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12954-020-00377-0","article-title":"Medical cannabis use in the Australian community following introduction of legal access: The 2018\u20132019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)","volume":"17","author":"Lintzeris","year":"2020","journal-title":"Harm. Reduct. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1176\/appi.ajp.2009.10030434","article-title":"Linking molecules to mood: New insight into the biology of depression","volume":"167","author":"Krishnan","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2174\/1871527313666140612114838","article-title":"Antidepressant-like and anxiolytic-like effects of cannabidiol: A chemical compound of Cannabis sativa","volume":"13","author":"Coutinho","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","article-title":"5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.physbeh.2018.12.019","article-title":"Effects of cannabidiol in males and females in two different rat models of depression","volume":"201","author":"Shbiro","year":"2019","journal-title":"Physiol. Behav."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000443890","article-title":"Pro-hedonic effect of cannabidiol in a rat model for depression","volume":"73","author":"Shoval","year":"2016","journal-title":"Neuropsychobiology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: Possible involvement of 5-HT1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"107894","DOI":"10.1016\/j.drugalcdep.2020.107894","article-title":"Cannabis use among youth in the United States, 2004\u20132016: Faster rate of increase among youth with depression","volume":"209","author":"Weinberger","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/da.20135","article-title":"Clinical characteristics of inpatient adolescents with severe obsessive-compulsive disorder","volume":"23","author":"Shoval","year":"2006","journal-title":"Depress. Anxiety"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: A patient-level meta-analysis","volume":"303","author":"Fournier","year":"2010","journal-title":"JAMA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000480456","article-title":"Long-term and short-term antidepressant use in general practice: Data from a large cohort in the Netherlands","volume":"86","author":"Huijbregts","year":"2017","journal-title":"Psychother. Psychosom."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.31887\/DCNS.2010.12.2\/mkellner","article-title":"Drug treatment of obsessive-compulsive disorder","volume":"12","author":"Kellner","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.euroneuro.2017.08.428","article-title":"Low adherence to antidepressants is associated with increased mortality following stroke: A large nationally representative cohort study","volume":"27","author":"Krivoy","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/01.jcp.0000220524.44905.9f","article-title":"The effects of topiramate adjunctive treatment added to antidepressants in patients with resistant obsessive-compulsive disorder","volume":"26","author":"Rubio","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_52","first-page":"27","article-title":"Prevalence of mental disorders, and trends from 1996 to 2009. Results from NEMESIS-2","volume":"54","year":"2012","journal-title":"Tijdschr. Psychiatr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.jpolmod.2020.06.001","article-title":"Macroeconomic determinants of antidepressant use","volume":"42","author":"Yetkiner","year":"2020","journal-title":"J. Policy. Model."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00228-014-1803-x","article-title":"Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: A dynamic population-based study","volume":"71","author":"Noordam","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2174\/0929867043455594","article-title":"Trends in the development of new antidepressants. Is there a light at the end of the tunnel?","volume":"11","author":"Pacher","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1176\/ps.2009.60.11.1466","article-title":"The STAR* D trial: Revealing the need for better treatments","volume":"60","author":"Insel","year":"2009","journal-title":"Psychiatr. Serv."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jpsychires.2011.09.020","article-title":"Impact of citalopram on the HPA system. A study of the combined DEX\/CRH test in 30 unipolar depressed patients","volume":"46","author":"Bschor","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4088\/JCP.9104su1c.03","article-title":"When should you move beyond first-line therapy for depression?","volume":"71","author":"McIntyre","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/01.jcp.0000085409.08426.4c","article-title":"Switching to reboxetine: An efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine","volume":"23","author":"Fava","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00787-016-0836-3","article-title":"Poor guideline adherence in the initiation of antidepressant treatment in children and adolescents in the Netherlands: Choice of antidepressant and dose","volume":"25","author":"Kalverdijk","year":"2016","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0197-2456(03)00112-0","article-title":"Sequenced treatment alternatives to relieve depression (STAR* D): Rationale and design","volume":"25","author":"Rush","year":"2004","journal-title":"Control. Clin. Trials"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMoa052963","article-title":"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression","volume":"354","author":"Rush","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jad.2006.04.029","article-title":"Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine","volume":"95","author":"Berlanga","year":"2006","journal-title":"J. Affect. Disord."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.genm.2009.12.004","article-title":"Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: An updated review","volume":"6","author":"Bigos","year":"2009","journal-title":"Gend. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1742-7843.2009.00516.x","article-title":"Sex differences in animal models of depression and antidepressant response","volume":"106","author":"Dalla","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1055\/s-0032-1312592","article-title":"Sex, stress, and mood disorders: At the intersection of adrenal and gonadal hormones","volume":"44","author":"Fiedler","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41386-018-0156-z","article-title":"Sex differences in antidepressant efficacy","volume":"44","author":"LeGates","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuint.2007.06.025","article-title":"Childhood and adolescent depression: Why do children and adults respond differently to antidepressant drugs?","volume":"51","author":"Bylund","year":"2007","journal-title":"Neurochem. Int."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1017\/S1461145703003663","article-title":"Age-dependent antidepressant pharmacogenomics: Polymorphisms of the serotonin transporter and G protein \u03b23 subunit as predictors of response to fluoxetine and nortriptyline","volume":"6","author":"Joyce","year":"2003","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0165-0327(02)00083-6","article-title":"Age may affect response to antidepressants with serotonergic and noradrenergic actions","volume":"76","author":"Mulder","year":"2003","journal-title":"J. Affect. Disord."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.4088\/JCP.10r06531","article-title":"Efficacy of antidepressants for late-life depression: A meta-analysis and meta-regression of placebo-controlled randomized trials","volume":"72","author":"Tedeschini","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/15622975.2014.1001786","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: Maintenance treatment of major depressive disorder-update 2015","volume":"16","author":"Bauer","year":"2015","journal-title":"World J. Biol. Psychiatry"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/ijnp\/pyy079","article-title":"From treatment response to recovery: A realistic goal in OCD","volume":"21","author":"Burchi","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_74","first-page":"51","article-title":"Long-term goals in the management of acute and chronic anxiety disorders","volume":"49","author":"Kjernisted","year":"2004","journal-title":"Can. J. Psychiatry"},{"key":"ref_75","first-page":"17","article-title":"Evidence-based strategies for achieving and sustaining full remission in depression: Focus on metaanalyses","volume":"49","author":"Lam","year":"2004","journal-title":"Can. J. Psychiatry"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1469-7610.2005.01467.x","article-title":"Review of the efficacy and safety of antidepressants in youth depression","volume":"46","author":"Cheung","year":"2005","journal-title":"J. Child Psychol. Psychiatry"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1037\/a0025933","article-title":"Remission after acute treatment in children and adolescents with anxiety disorders: Findings from the CAMS","volume":"79","author":"Ginsburg","year":"2011","journal-title":"J. Consult. Clin. Psychol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/104454603322126340","article-title":"Remission status after long-term sertraline treatment of pediatric obsessive-compulsive disorder","volume":"13","author":"Wagner","year":"2003","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1177\/0269881113492027","article-title":"A review of the adverse effects and safety of noradrenergic antidepressants","volume":"27","author":"Whiskey","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/cap.2007.0061","article-title":"QT interval and dispersion in very young children treated with antipsychotic drugs: A retrospective chart review","volume":"17","author":"Nahshoni","year":"2007","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4088\/JCP.v65n0712","article-title":"Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: Patient report versus physician estimate","volume":"65","author":"Hu","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"ref_82","first-page":"Doc15","article-title":"Which adverse effects influence the dropout rate in selective serotonin reuptake inhibitor (SSRI) treatment? Results for 50,824 patients","volume":"12","author":"Kostev","year":"2014","journal-title":"Ger. Med. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3200\/BMED.32.4.127-134","article-title":"Predictors of self-reported antidepressant adherence","volume":"32","author":"Burra","year":"2007","journal-title":"Behav. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00228-013-1582-9","article-title":"Risk factors for non-adherence to antidepressant treatment in patients with mood disorders","volume":"70","author":"Sanz","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/13607863.2019.1594165","article-title":"The association between side effects and adherence to antidepressants among primary care community-dwelling older adults","volume":"24","author":"Milan","year":"2020","journal-title":"Aging Ment. Health"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2147\/NDT.S67008","article-title":"Examining the relationship between adherence and satisfaction with antidepressant treatment","volume":"10","author":"Aljumah","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0140-6736(03)12599-8","article-title":"Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review","volume":"361","author":"Geddes","year":"2003","journal-title":"Lancet"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Sawada, N., Uchida, H., Suzuki, T., Watanabe, K., Kikuchi, T., Handa, T., and Kashima, H. (2009). Persistence and compliance to antidepressant treatment in patients with depression: A chart review. BMC Psychiatry, 9.","DOI":"10.1186\/1471-244X-9-38"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.sapharm.2011.04.002","article-title":"The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder","volume":"8","author":"Wu","year":"2012","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_90","first-page":"1327","article-title":"Determinants of antidepressant treatment outcome","volume":"6","author":"Sood","year":"2000","journal-title":"Am. J. Manag. Care"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4088\/JCP.10m06098","article-title":"Response rates to fluoxetine in subjects who initially show no improvement","volume":"72","author":"Posternak","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"ref_92","first-page":"18","article-title":"Evaluating antidepressant therapies: Remission as the optimal outcome","volume":"64","author":"Thase","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/chi.0b013e318145ae1c","article-title":"Practice parameter for the assessment and treatment of children and adolescents with depressive disorders","volume":"46","author":"Birmaher","year":"2007","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4088\/JCP.14m09531","article-title":"Adherence to antidepressants is associated with lower mortality: A 4-year population-based cohort study","volume":"77","author":"Krivoy","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1192\/bjp.bp.114.155820","article-title":"Adherence to antidepressant therapy and mortality rates in ischaemic heart disease: Cohort study","volume":"206","author":"Krivoy","year":"2015","journal-title":"Br. J. Psychiatry"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.parkreldis.2017.07.032","article-title":"Low adherence to antidepressants is associated with increased mortality in Parkinson disease patients","volume":"43","author":"Shoval","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/da.22938","article-title":"Adherence to antidepressant medications is associated with reduced premature mortality in patients with cancer: A nationwide cohort study","volume":"36","author":"Shoval","year":"2019","journal-title":"Depress. Anxiety"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/archinte.166.5.498","article-title":"Physician alerts to increase antidepressant adherence: Fax or fiction?","volume":"166","author":"Bambauer","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"ref_99","first-page":"91","article-title":"A cohort study of adherence to antidepressants in primary care: The influence of antidepressant concerns and treatment preferences. Prim. Care Companion","volume":"9","author":"Hunot","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/archgenpsychiatry.2009.81","article-title":"National patterns in antidepressant medication treatment","volume":"66","author":"Olfson","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0706743718802809","article-title":"Adherence to and persistence with antidepressant medication during pregnancy: Does it differ by the class of antidepressant medication prescribed?","volume":"64","author":"Adhikari","year":"2019","journal-title":"Can J. Psychiatry"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1345\/aph.1Q020","article-title":"Factors associated with antidepressant adherence for Medicaid-enrolled children and adolescents","volume":"45","author":"Fontanella","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/da.22532","article-title":"Antidepressant adherence across diverse populations and healthcare settings","volume":"33","author":"Rossom","year":"2016","journal-title":"Depress. Anxiety"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1007\/s00213-015-3988-9","article-title":"The impact of age and gender on adherence to antidepressants: A 4-year population-based cohort study","volume":"232","author":"Krivoy","year":"2015","journal-title":"Psychopharmacology"},{"key":"ref_105","first-page":"607","article-title":"Review of the Endocannabinoid System","volume":"6","author":"Lu","year":"2021","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-2236(98)01283-1","article-title":"Endocannabinoids: Endogenous cannabinoid receptor ligands with neuromodulatory action","volume":"21","author":"Melck","year":"1998","journal-title":"Trends Neurosci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4088\/JCP.15m09938","article-title":"Characteristics of synthetic cannabinoid and cannabis users admitted to a psychiatric hospital: A comparative study","volume":"77","author":"Shalit","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1073\/pnas.1612177114","article-title":"Endocannabinoid system acts as a regulator of immune homeostasis in the gut","volume":"114","author":"Acharya","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2016.04.031","article-title":"Dissociating the role of endocannabinoids in the pleasurable and motivational properties of social play behaviour in rats","volume":"110","author":"Achterberg","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"653","DOI":"10.5665\/sleep.5546","article-title":"Sleep restriction enhances the daily rhythm of circulating levels of endocannabinoid 2-arachidonoylglycerol","volume":"39","author":"Hanlon","year":"2016","journal-title":"Sleep"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Meccariello, R., and Chianese, R. (2016). Cannabinoids and motor control of the basal ganglia: Therapeutic potential in movement disorders. Cannabinoids in Health and Disease, InTech.","DOI":"10.5772\/61595"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1007\/s12035-016-0313-5","article-title":"Endocannabinoid system: The direct and indirect involvement in the memory and learning processes\u2014A short review","volume":"54","author":"Dzik","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10286-017-0488-5","article-title":"The endocannabinoid system in cardiovascular function: Novel insights and clinical implications","volume":"28","author":"Sierra","year":"2018","journal-title":"Clin. Auton. Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nn.3647","article-title":"The endocannabinoid system controls food intake via olfactory processes","volume":"17","author":"Bellocchio","year":"2014","journal-title":"Nat. Neurosci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1476-5381.2010.00745.x","article-title":"Phytocannabinoids beyond the Cannabis plant\u2013do they exist?","volume":"160","author":"Gertsch","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1039\/C6NP00074F","article-title":"Phytocannabinoids: A unified critical inventory","volume":"33","author":"Meyer","year":"2016","journal-title":"Nat. Prod. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.15376\/biores.9.2.Khan","article-title":"Antibacterial properties of hemp and other natural fibre plants: A review","volume":"9","author":"Khan","year":"2014","journal-title":"BioResources"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fpls.2016.00019","article-title":"Cannabis sativa: The plant of the thousand and one molecules","volume":"7","author":"Andre","year":"2016","journal-title":"Front. Plant Sci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1152\/physrev.00002.2016","article-title":"From phytocannabinoids to cannabinoid receptors and endocannabinoids: Pleiotropic physiological and pathological roles through complex pharmacology","volume":"96","author":"Ligresti","year":"2016","journal-title":"Physiol. Rev."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.2174\/13816128113199990432","article-title":"Neuroimaging studies of acute effects of THC and CBD in humans and animals: A systematic review","volume":"20","author":"Batalla","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of \u0394-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s40429-017-0142-2","article-title":"Does cannabis composition matter? Differential effects of delta-9-tetrahydrocannabinol and cannabidiol on human cognition","volume":"4","author":"Colizzi","year":"2017","journal-title":"Curr. Addict. Rep."},{"key":"ref_124","first-page":"151","article-title":"Cannabinoid pharmacology","volume":"38","author":"Dewey","year":"1986","journal-title":"Pharmacol. Rev."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"Chiaretti","year":"1990","journal-title":"Psychopharmacology"},{"key":"ref_126","first-page":"1","article-title":"Industrial hemp (Cannabis sativa L.): The geography of a controversial plant","volume":"41","author":"Luginbuhl","year":"2001","journal-title":"Calif. Geogr."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.yebeh.2016.11.021","article-title":"The legal status of cannabis (marijuana) and cannabidiol (CBD) under US law","volume":"70","author":"Mead","year":"2017","journal-title":"Epilepsy Behav."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1749-6632.1971.tb13995.x","article-title":"Tetrahydrocannabinol and the marijuana-induced social \u201chigh,\u201d or the effects of the mind on marijuana","volume":"191","author":"Jones","year":"1971","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jamapsychiatry.2020.0339","article-title":"Will legalization and commercialization of cannabis use increase the incidence and prevalence of psychosis?","volume":"77","author":"Murray","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1037\/h0029858","article-title":"Dimensions of marijuana usage in a land-grant university","volume":"17","author":"DeFleur","year":"1970","journal-title":"J. Couns. Psychol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/add.12703","article-title":"What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?","volume":"110","author":"Hall","year":"2015","journal-title":"Addiction"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/YCO.0b013e32812144cc","article-title":"Prevalence and correlates of cannabis use in developed and developing countries","volume":"20","author":"Hall","year":"2007","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/ajad.12401","article-title":"Sociodemographic and drug use severity differences between medical marijuana users and non-medical users visiting the emergency department","volume":"25","author":"Woodruff","year":"2016","journal-title":"Am. J. Addict."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/bmj.325.7374.1195","article-title":"Cannabis use and mental health in young people: Cohort study","volume":"325","author":"Patton","year":"2002","journal-title":"BMJ"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/npp.2013.51","article-title":"Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory","volume":"38","author":"Abush","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.mce.2008.02.006","article-title":"Neurobiological mechanisms of cannabinoid addiction","volume":"286","author":"Fattore","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/npp.2011.204","article-title":"Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress","volume":"37","author":"Akirav","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0079-6123(08)00433-0","article-title":"Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis","volume":"170","author":"Steiner","year":"2008","journal-title":"Prog. Brain Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/09595239800187271","article-title":"Cannabis use and psychosis","volume":"17","author":"Hall","year":"1998","journal-title":"Drug. Alcohol Rev."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archpsyc.1994.03950040017002","article-title":"Cannabis abuse and the course of recent-onset schizophrenic disorders","volume":"51","author":"Linszen","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3109\/00048671003689710","article-title":"Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: Impact on psychotic-and pre-psychotic symptoms","volume":"44","author":"Machielsen","year":"2010","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamapsychiatry.2016.2427","article-title":"Association between continued cannabis use and risk of relapse in first-episode psychosis: A quasi-experimental investigation within an observational study","volume":"73","author":"Schoeler","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.janxdis.2011.12.006","article-title":"Social anxiety and cannabis use: An analysis from ecological momentary assessment","volume":"26","author":"Buckner","year":"2012","journal-title":"J. Anxiety Disord."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/00952991003713784","article-title":"Anxiety and mood disorders and cannabis use","volume":"36","author":"Cheung","year":"2010","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Kedzior, K.K., and Laeber, L.T. (2014). A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population-a meta-analysis of 31 studies. BMC Psychiatry, 14.","DOI":"10.1186\/1471-244X-14-136"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1001\/jamapsychiatry.2018.4500","article-title":"Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: A systematic review and meta-analysis","volume":"76","author":"Gobbi","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jad.2016.07.010","article-title":"The association between cannabis use and suicidality among men and women: A population-based longitudinal study","volume":"205","author":"Shalit","year":"2016","journal-title":"J. Affect. Disord."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.addbeh.2017.11.005","article-title":"The association between adolescent cannabis use and anxiety: A parallel process analysis","volume":"78","author":"Duperrouzel","year":"2018","journal-title":"Addict. Behav."},{"key":"ref_150","unstructured":"Abel, E.L. (2013). Marihuana: The First Twelve Thousand Years, Springer Science & Business Media."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"129","DOI":"10.14740\/jocmr4090","article-title":"Dosage, efficacy and safety of cannabidiol administration in adults: A systematic review of human trials","volume":"12","author":"Larsen","year":"2020","journal-title":"J. Clin. Med. Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2174\/1871527316666170413114210","article-title":"Neurological aspects of medical use of cannabidiol","volume":"16","author":"Mannucci","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"538670","DOI":"10.1155\/2015\/538670","article-title":"Evaluation of serum cytokines levels and the role of cannabidiol treatment in animal model of asthma","volume":"2015","author":"Vuolo","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1017\/S0033291711001322","article-title":"Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being","volume":"42","author":"Morgan","year":"2012","journal-title":"Psychol. Med."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: New therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10681-004-4756-9","article-title":"Pharmacological and therapeutic targets for \u0394 9 tetrahydrocannabinol and cannabidiol","volume":"140","author":"Pertwee","year":"2014","journal-title":"Euphytica"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1590\/S1516-44462008000300015","article-title":"Cannabidiol: From an inactive cannabinoid to a drug with wide spectrum of action","volume":"30","author":"Zuardi","year":"2008","journal-title":"Braz. J. Psychiatry"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FBP.0b013e32833b33c5","article-title":"Cannabidiol inhibitory effect on marble-burying behaviour: Involvement of CB1 receptors","volume":"21","author":"Casarotto","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00213-011-2415-0","article-title":"Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), \u0394 9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive\u2013compulsive behaviour","volume":"219","author":"Deiana","year":"2012","journal-title":"Psychopharmacology"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/fcp.12051","article-title":"Cannabidiol reverses the mCPP-induced increase in marble-burying behavior","volume":"28","author":"Nardo","year":"2014","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-009-1466-y","article-title":"Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety","volume":"204","author":"Thomas","year":"2009","journal-title":"Psychopharmacology"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1007\/s00213-016-4383-x","article-title":"Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: An evaluation of the cannabis \u2018amotivational\u2019 hypotheses","volume":"233","author":"Lawn","year":"2016","journal-title":"Psychopharmacology"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2337\/dc09-1029","article-title":"Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy: Depression is a major confounding factor","volume":"33","author":"Selvarajah","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","article-title":"Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain","volume":"160","author":"McLaughlin","year":"2019","journal-title":"Pain"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2018.05.027","article-title":"Acute oral cannabidiolic acid methyl ester reduces depression-like behavior in two genetic animal models of depression","volume":"351","author":"Amar","year":"2018","journal-title":"Behav. Brain Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bph.14073","article-title":"Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5-HT1A receptor-mediated suppression of nausea and anxiety in rats","volume":"175","author":"Pertwee","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00213-017-4626-5","article-title":"Effect of prior foot shock stress and \u0394 9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats","volume":"234","author":"Rock","year":"2017","journal-title":"Psychopharmacology"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1742-1241.2004.00271.x","article-title":"The medicinal use of cannabis in the UK: Results of a nationwide survey","volume":"59","author":"Ware","year":"2005","journal-title":"Int. J. Clin. Pract."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.psyneuen.2008.08.018","article-title":"HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients","volume":"34","author":"Binder","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ncpendmet0403","article-title":"Therapy insight: Is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression?","volume":"3","author":"DeRijk","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2018.10.008","article-title":"Role of corticosterone in anxiety-and depressive-like behavior and HPA regulation following prenatal alcohol exposure","volume":"90","author":"Lam","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/S1461145704004080","article-title":"Antidepressants and brain monoaminergic systems: A dimensional approach to understanding their behavioural effects in depression and anxiety disorders","volume":"7","author":"Morilak","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2826.2008.01673.x","article-title":"The role of the endocannabinoid system in the regulation of hypothalamic-pituitary-adrenal axis activity","volume":"20","author":"Cota","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.euroneuro.2005.03.003","article-title":"Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test","volume":"15","author":"Hill","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00008877-200509000-00005","article-title":"A role for cannabinoid CB1 receptors in mood and anxiety disorders","volume":"16","author":"Witkin","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/187152709789824624","article-title":"The endocannabinoid system and the treatment of mood and anxiety disorders","volume":"8","author":"Hill","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pbb.2005.01.029","article-title":"Endocannabinoid system and stress and anxiety responses","volume":"81","author":"Viveros","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1017\/S0033291713001438","article-title":"The association between cannabis use and depression: A systematic review and meta-analysis of longitudinal studies","volume":"44","author":"Roerecke","year":"2014","journal-title":"Psychol. Med."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jad.2014.10.006","article-title":"The association between cannabis use and mood disorders: A longitudinal study","volume":"172","author":"Feingold","year":"2015","journal-title":"J. Affect. Disord."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00213-008-1422-2","article-title":"The effects of cannabinoids on serum cortisol and prolactin in humans","volume":"203","author":"Ranganathan","year":"2009","journal-title":"Psychopharmacology"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Vaughn, S.E., Strawn, J.R., Poweleit, E.A., Sarangdhar, M., and Ramsey, L.B. (2021). The impact of marijuana on antidepressant treatment in adolescents: Clinical and pharmacologic considerations. J. Pers. Med., 11.","DOI":"10.3390\/jpm11070615"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/0024-3205(96)00066-5","article-title":"Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function","volume":"58","author":"Dinan","year":"1996","journal-title":"Life Sci."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0165-0327(98)00221-3","article-title":"Mechanism of action of serotonin selective reuptake inhibitors: Serotonin receptors and pathways mediate therapeutic effects and side effects","volume":"51","author":"Stahl","year":"1998","journal-title":"J. Affect. Disord."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"S302","DOI":"10.1016\/S0924-9338(05)80180-4","article-title":"The HPA and immune axes in stress: The involvement of the serotonergic system","volume":"20","author":"Leonard","year":"2005","journal-title":"Eur. Psychiatry"},{"key":"ref_186","first-page":"39","article-title":"5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs?","volume":"30","author":"Stahl","year":"1994","journal-title":"Psychopharmacol. Bull."},{"key":"ref_187","first-page":"12","article-title":"Pharmacology of rapid-onset antidepressant treatment strategies","volume":"62","author":"Blier","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1099-1077(200003)15:2<113::AID-HUP150>3.0.CO;2-W","article-title":"5-HT1A and beyond: The role of serotonin and its receptors in depression and the antidepressant response","volume":"15","author":"Cryan","year":"2000","journal-title":"Hum. Psychopharmacol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00406-009-0035-z","article-title":"5HT1A-mediated stimulation of cortisol release in major depression: Use of non-invasive cortisol measurements to predict clinical response","volume":"260","author":"Papakostas","year":"2010","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2006.10.038","article-title":"5-HT1A receptors are involved in the anxiolytic effect of \u03949-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague\u2013Dawley rats","volume":"555","author":"Braida","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0091-3057(01)00567-6","article-title":"Involvement of somatodendritic 5-HT1A receptors in \u03949-tetrahydrocannabinol-induced hypothermia in the rat","volume":"69","author":"Malone","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","article-title":"Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats","volume":"199","author":"Campos","year":"2008","journal-title":"Psychopharmacology"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.neuropharm.2006.11.005","article-title":"Repeated treatment with cannabidiol but not \u03949-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance","volume":"52","author":"Hayakawa","year":"2007","journal-title":"Neuropharmacology"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bbr.2006.05.016","article-title":"Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats","volume":"172","author":"Resstel","year":"2006","journal-title":"Behav. Brain Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/dneu.20758","article-title":"The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity","volume":"70","year":"2010","journal-title":"Dev. Neurobiol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"10827","DOI":"10.1073\/pnas.0402141101","article-title":"Essential role of brain-derived neurotrophic factor in adult hippocampal function","volume":"101","author":"Monteggia","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF\u2013a key transducer of antidepressant effects","volume":"102","author":"Monteggia","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments","volume":"15","author":"Nibuya","year":"1995","journal-title":"J. Neurosci."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1471-4159.2005.03074.x","article-title":"In vivo up-regulation of brain-derived neurotrophic factor in specific brain areas by chronic exposure to \u03949-tetrahydrocannabinol","volume":"93","author":"Butovsky","year":"2005","journal-title":"J. Neurochem."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1523\/JNEUROSCI.23-06-02371.2003","article-title":"Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus","volume":"23","author":"Derkinderen","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1111\/j.1460-9568.2007.05565.x","article-title":"Long-term reduction of brain-derived neurotrophic factor levels and signaling impairment following prenatal treatment with the cannabinoid receptor 1 receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl) pyrrolo [1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone","volume":"25","author":"Maj","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1385\/MN:33:3:199","article-title":"Changes in the expression of G protein-coupled receptor kinases and \u03b2-arrestins in mouse brain during cannabinoid tolerance","volume":"33","author":"Rubino","year":"2006","journal-title":"Mol. Neurobiol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.fitote.2016.11.010","article-title":"Target regulation of PI3K\/Akt\/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis","volume":"116","author":"Giacoppo","year":"2017","journal-title":"Fitoterapia"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pnpbp.2016.11.005","article-title":"Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia","volume":"75","author":"Mori","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s12035-018-1143-4","article-title":"Cannabidiol induces rapid and sustained antidepressant-like effects through increased BDNF signaling and synaptogenesis in the prefrontal cortex","volume":"56","author":"Sales","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00213-008-1333-2","article-title":"Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans","volume":"202","author":"Pittman","year":"2009","journal-title":"Psychopharmacology"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","article-title":"Gut\u2013brain axis: How the microbiome influences anxiety and depression","volume":"36","author":"Foster","year":"2013","journal-title":"Trends Neurosci."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.copbio.2014.10.007","article-title":"Gut brain axis: Diet microbiota interactions and implications for modulation of anxiety and depression","volume":"32","author":"Luna","year":"2015","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/FBP.0000000000000478","article-title":"Stress and the gut microbiota-brain axis","volume":"30","author":"Roman","year":"2019","journal-title":"Behav. Pharmacol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jad.2016.09.012","article-title":"Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness","volume":"208","author":"Macedo","year":"2017","journal-title":"J. Affect. Disord."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/s41398-017-0031-4","article-title":"Possible role of the gut microbiota\u2013brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model","volume":"7","author":"Yang","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"14290","DOI":"10.1038\/s41598-019-50807-8","article-title":"Oral selective serotonin reuptake inhibitors activate vagus nerve dependent gut-brain signalling","volume":"9","author":"Neufeld","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrendo.2015.211","article-title":"Endocannabinoids\u2014at the crossroads between the gut microbiota and host metabolism","volume":"12","author":"Cani","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/msb.2010.46","article-title":"The endocannabinoid system links gut microbiota to adipogenesis","volume":"6","author":"Muccioli","year":"2010","journal-title":"Mol. Syst. Biol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1053\/j.gastro.2016.04.015","article-title":"The role of the endocannabinoid system in the brain\u2013gut axis","volume":"151","author":"Sharkey","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"G565","DOI":"10.1152\/ajpgi.00158.2011","article-title":"Endogenous cannabinoid system regulates intestinal barrier function in vivo through cannabinoid type 1 receptor activation","volume":"302","author":"Zoppi","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.13416","article-title":"Recent developments in understanding the role of the gut microbiota in brain health and disease","volume":"1420","author":"Sherwin","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/acer.14256","article-title":"Cannabinoids and the Microbiota\u2013Gut\u2013Brain Axis: Emerging Effects of Cannabidiol and Potential Applications to Alcohol Use Disorders","volume":"44","author":"Karoly","year":"2020","journal-title":"Alcohol Clin. Exp. Res."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-5728(97)00227-0","article-title":"Drugs and immunity: Cannabinoids and their role in decreased resistance to infectious disease","volume":"83","author":"Cabral","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2005.04.023","article-title":"Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?","volume":"166","author":"Croxford","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0165-5728(97)00226-9","article-title":"Marijuana, immunity and infection","volume":"83","author":"Klein","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.2174\/138161206777947425","article-title":"Cannabinoids, immune system and cytokine network","volume":"12","author":"Massi","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0009-3084(02)00159-7","article-title":"Effects of delta-9-tetrahydrocannabinol on human immune function and host defense","volume":"1211","author":"Roth","year":"2002","journal-title":"Chem. Phys. Lipids"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.psyneuen.2012.03.019","article-title":"Neuroplastic changes in depression: A role for the immune system","volume":"37","author":"Eyre","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/15622970009150562","article-title":"Stress, depression and the activation of the immune system","volume":"1","author":"Leonard","year":"2000","journal-title":"World J. Biol. Psychiatry"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0278-5846(01)00155-5","article-title":"The immune system, depression and the action of antidepressants","volume":"25","author":"Leonard","year":"2001","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0091-3057(95)02158-2","article-title":"Stress and the immune system in the etiology of anxiety and depression","volume":"54","author":"Leonard","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2466\/pr0.1981.49.3.969","article-title":"Anxiety and immune responsiveness","volume":"49","author":"Linn","year":"1981","journal-title":"Psychol. Rep."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"18053","DOI":"10.1073\/pnas.0809479105","article-title":"Brain mast cells link the immune system to anxiety-like behavior","volume":"105","author":"Nautiyal","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0193-953X(05)70015-0","article-title":"Neuroendocrine and immune system interactions in stress and depression","volume":"21","author":"Miller","year":"1998","journal-title":"Psychiatr. Clin. N. Am."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0193-953X(18)30502-1","article-title":"Immune system: Relationship to anxiety disorders","volume":"11","author":"Stein","year":"1988","journal-title":"Psychiatr. Clin. N. Am."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/02791072.2015.1014121","article-title":"Cannabis use and quality of life of adolescents and young adults: Findings from an Australian birth cohort","volume":"47","author":"Fischer","year":"2015","journal-title":"J. Psychoact. Drugs"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev-pharmtox-010716-104615","article-title":"Don\u2019t worry, be happy: Endocannabinoids and cannabis at the intersection of stress and reward","volume":"57","author":"Volkow","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1046\/j.1360-0443.2001.961116037.x","article-title":"Alcohol, cannabis and tobacco use among Australians: A comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis","volume":"96","author":"Degenhardt","year":"2001","journal-title":"Addiction"},{"key":"ref_236","unstructured":"United Nations Office on Drugs and Crime (UNODC) (2020, October 21). World Drug Report, United Nations Office on Drugs and Crime. Available online: https:\/\/www.unodc.org\/documents\/wdr2015\/World_Drug_Report_2015.pdf."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3122\/jabfm.2011.04.100280","article-title":"Cannabis and its derivatives: Review of medical use","volume":"24","author":"Leung","year":"2011","journal-title":"J. Am. Board Fam. Med."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/WNF.0000000000000016","article-title":"Cannabis (medical marijuana) treatment for motor and non\u2013motor symptoms of Parkinson disease: An open-label observational study","volume":"37","author":"Lotan","year":"2014","journal-title":"Clin. Neuropharmacol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jpainsymman.2004.07.011","article-title":"Cannabis use in HIV for pain and other medical symptoms","volume":"29","author":"Woolridge","year":"2005","journal-title":"J. Pain Symptom Manag."},{"key":"ref_240","unstructured":"Anthony, J.C., and Helzer, J.E. (1991). Syndromes of Drug Abuse and Dependence. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study, The Free Press."},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (DSM-5\u00ae), American Psychiatric Pub.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0376-8716(80)90192-1","article-title":"Laboratory verification of \u201cheavy\u201d and \u201clight\u201d users of cannabis","volume":"5","author":"Hollister","year":"1980","journal-title":"Drug Alcohol Depend."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1111\/j.1360-0443.2011.03574.x","article-title":"Cannabis use and cognitive function: 8-year trajectory in a young adult cohort","volume":"106","author":"Tait","year":"2011","journal-title":"Addiction"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/dar.12412","article-title":"Comparison of cannabinoids in hair with self-reported cannabis consumption in heavy, light and non-cannabis users","volume":"36","author":"Taylor","year":"2017","journal-title":"Drug Alcohol Rev."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/1\/523\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:36:05Z","timestamp":1760362565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/1\/523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":244,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["ijerph19010523"],"URL":"https:\/\/doi.org\/10.3390\/ijerph19010523","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]}}}